OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TGVS57

TGV SRAAC Ltd

Commodity ChemicalsVerified

TGV SRAAC maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating a relatively low reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.14, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of INR 260.9 million indicates some capacity for reinvestment or shareholder returns, though it is modest relative to operating cash flow of INR 1.95 billion. Profitability metrics show a return on equity (ROE) of 7.82% and a return on assets (ROA) of 4.68%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of INR 1.37 billion on revenue of INR 17.49 billion, is 7.88%, which is in line with the industry's median for commodity chemical producers. However, the net profit margin of 5.27% (INR 921.2 million on INR 17.49 billion revenue) suggests some pressure from operating and non-operating expenses. The company's revenue is split between two segments: Chemicals and Oils & Fats. While the input data does not provide segment-specific revenue figures, the disclosed product mix indicates a significant exposure to chlor-alkali and castor-based derivatives. Geographically, the company is concentrated in India, with no disclosed international operations, which may limit diversification and expose it to domestic economic and regulatory risks. Looking ahead, the company's revenue is expected to grow, though the exact rate is not specified. Historical revenue of INR 17.49 billion provides a baseline for assessing future performance. The capital expenditure of INR -1.44 billion (negative, indicating outflows) suggests ongoing investment in infrastructure or production capacity, which could support long-term growth. However, the negative net cash position (cash and equivalents of INR 91.5 million vs. long-term debt of INR 3.55 billion) raises concerns about liquidity risk. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's diluted shares are equal to its basic shares, indicating no imminent threat of equity dilution. However, the negative net cash position after subtracting total debt is a key flag, suggesting potential pressure to secure additional financing or manage working capital more effectively. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's exposure to commodity chemicals and its domestic focus in India suggest that macroeconomic conditions, regulatory changes, and input cost fluctuations will be critical to monitor in the near term.

30-day price · TGVS+26.37 (+31.1%)
Low$78.41High$117.00Close$111.25As of12 May, 00:00 UTC
Profile
CompanyTGV SRAAC Ltd
TickerTGVS.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. TGV SRAAC Limited produces chlor-alkali products, chloromethane, castor derivatives, and fatty acids, generating revenue through the sale of caustic soda, chlorine, hydrochloric acid, and related chemical and oil products.

Classification. TGV SRAAC is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

TGV SRAAC maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating a relatively low reliance on debt financing. The company's liquidity position is moderate, with a current ratio of 1.14, suggesting it can cover short-term obligations but with limited buffer. Free cash flow of INR 260.9 million indicates some capacity for reinvestment or shareholder returns, though it is modest relative to operating cash flow of INR 1.95 billion. Profitability metrics show a return on equity (ROE) of 7.82% and a return on assets (ROA) of 4.68%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of INR 1.37 billion on revenue of INR 17.49 billion, is 7.88%, which is in line with the industry's median for commodity chemical producers. However, the net profit margin of 5.27% (INR 921.2 million on INR 17.49 billion revenue) suggests some pressure from operating and non-operating expenses. The company's revenue is split between two segments: Chemicals and Oils & Fats. While the input data does not provide segment-specific revenue figures, the disclosed product mix indicates a significant exposure to chlor-alkali and castor-based derivatives. Geographically, the company is concentrated in India, with no disclosed international operations, which may limit diversification and expose it to domestic economic and regulatory risks. Looking ahead, the company's revenue is expected to grow, though the exact rate is not specified. Historical revenue of INR 17.49 billion provides a baseline for assessing future performance. The capital expenditure of INR -1.44 billion (negative, indicating outflows) suggests ongoing investment in infrastructure or production capacity, which could support long-term growth. However, the negative net cash position (cash and equivalents of INR 91.5 million vs. long-term debt of INR 3.55 billion) raises concerns about liquidity risk. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's diluted shares are equal to its basic shares, indicating no imminent threat of equity dilution. However, the negative net cash position after subtracting total debt is a key flag, suggesting potential pressure to secure additional financing or manage working capital more effectively. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's exposure to commodity chemicals and its domestic focus in India suggest that macroeconomic conditions, regulatory changes, and input cost fluctuations will be critical to monitor in the near term.
Key takeaways
  • TGV SRAAC maintains a conservative debt-to-equity ratio of 0.3, indicating a relatively low reliance on debt financing.
  • The company's ROE of 7.82% and ROA of 4.68% are below the typical thresholds for high-performing chemical firms.
  • Revenue is concentrated in India, with no disclosed international operations, which may limit diversification.
  • The company's negative net cash position after subtracting total debt is a key liquidity risk.
  • Capital expenditure of INR -1.44 billion suggests ongoing investment in infrastructure or production capacity.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$17.49B
Gross profit$5.73B
Operating income$1.37B
Net income$921.2M
R&D
SG&A
D&A
SBC
Operating cash flow$1.95B
CapEx-$1.44B
Free cash flow$260.9M
Total assets$19.68B
Total liabilities$7.89B
Total equity$11.78B
Cash & equivalents$91.5M
Long-term debt$3.55B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.78B
Net cash-$3.46B
Current ratio1.1
Debt/Equity0.3
ROA4.7%
ROE7.8%
Cash conversion2.1%
CapEx/Revenue-8.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricTGVSActivity
Op margin7.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin5.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin32.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity30.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 14:24 UTC#75fe5afc
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 14:26 UTCJob: 780b5401